Literature DB >> 11078776

Relapse, remission, and progression in multiple sclerosis.

W I McDonald.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 11078776     DOI： 10.1056/NEJM200011163432010

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  13 in total

1.  Meeting the needs of people with primary progressive multiple sclerosis, their families, and the health-care community.

Authors:  Nancy J Holland; Diana M Schneider; Robert Rapp; Rosalind C Kalb
Journal:  Int J MS Care       Date:  2011

Review 2.  Multiple sclerosis.

Authors:  Massimo Filippi; Amit Bar-Or; Fredrik Piehl; Paolo Preziosa; Alessandra Solari; Sandra Vukusic; Maria A Rocca
Journal:  Nat Rev Dis Primers       Date:  2018-11-08       Impact factor: 52.329

3.  Axonal damage accumulates in the progressive phase of multiple sclerosis: three year follow up study.

Authors:  A Petzold; M J Eikelenboom; G Keir; D Grant; R H C Lazeron; C H Polman; B M J Uitdehaag; E J Thompson; G Giovannoni
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-02       Impact factor: 10.154

4.  Impact of exposure to interferon beta-1a on outcomes in patients with relapsing-remitting multiple sclerosis: exploratory analyses from the PRISMS long-term follow-up study.

Authors:  Bernard Uitdehaag; Cris Constantinescu; Peter Cornelisse; Douglas Jeffery; Ludwig Kappos; David Li; Magnhild Sandberg-Wollheim; Anthony Traboulsee; Elisabetta Verdun; Victor Rivera
Journal:  Ther Adv Neurol Disord       Date:  2011-01       Impact factor: 6.570

5.  Disease-modifying therapies in relapsing-remitting multiple sclerosis.

Authors:  Fabricio González-Andrade; José Luis Alcaraz-Alvarez
Journal:  Neuropsychiatr Dis Treat       Date:  2010-09-07       Impact factor: 2.570

6.  Cerebrospinal fluid evidence of increased extra-mitochondrial glucose metabolism implicates mitochondrial dysfunction in multiple sclerosis disease progression.

Authors:  William T Regenold; Pornima Phatak; Michael J Makley; Roger D Stone; Mitchel A Kling
Journal:  J Neurol Sci       Date:  2008-09-09       Impact factor: 3.181

7.  Gray matter N-acetyl aspartate deficits in secondary progressive but not relapsing-remitting multiple sclerosis.

Authors:  Elfar Adalsteinsson; Annette Langer-Gould; Ronald J Homer; Archana Rao; Edith V Sullivan; Christiane Abbehusen Lima; Adolf Pfefferbaum; Scott W Atlas
Journal:  AJNR Am J Neuroradiol       Date:  2003 Nov-Dec       Impact factor: 3.825

8.  The MS Choices Survey: findings of a study assessing physician and patient perspectives on living with and managing multiple sclerosis.

Authors:  Alberto Riñon; Mandy Buch; Derek Holley; Elisabetta Verdun
Journal:  Patient Prefer Adherence       Date:  2011-12-28       Impact factor: 2.711

9.  Genes implicated in multiple sclerosis pathogenesis from consilience of genotyping and expression profiles in relapse and remission.

Authors:  Ariel T Arthur; Patricia J Armati; Chris Bye; Robert N S Heard; Graeme J Stewart; John D Pollard; David R Booth
Journal:  BMC Med Genet       Date:  2008-03-19       Impact factor: 2.103

10.  Prediction of acute multiple sclerosis relapses by transcription levels of peripheral blood cells.

Authors:  Michael Gurevich; Tamir Tuller; Udi Rubinstein; Rotem Or-Bach; Anat Achiron
Journal:  BMC Med Genomics       Date:  2009-07-22       Impact factor: 3.063
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.